Suboxone vs. Vivitrol for Opioid Use Disorder: How Do you Choose?
The Carlat Addiction Treatment Report, Volume 9, Number 7&8, November 2021
Gregory Lande, MD.
Dr. Lande has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buprenorphine and long acting injectable naltrexone are both effective for the treatment of opioid use disorder; however, until now, we had little data to predict which patients would do better on which medications. Here, researchers identify patient characteristics predictive of success on buprenorphine versus naltrexone.